AJP - Heart and Circulatory Physiology, Vol 267, Issue 5 1753-H1758, Copyright © 1994 by American Physiological Society

ARTICLES

IL-1 inhibits beta-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway

G. J. Rozanski and R. C. Witt
Department of Physiology, University of Nebraska College of Medicine, Omaha 68198-4575.

Modulation of the beta-adrenergic control of cardiac L-type Ca2+ current (Ica) by human recombinant interleukin-1 beta (IL-1) was examined in adult guinea pig ventricular myocytes using the whole cell voltage-clamp technique. ICa was elicited in Cs(+)-loaded myocytes by depolarizing pulses from a holding potential of -40 mV. Isoproterenol (0.01 and 1 microM) exposed to myocytes pretreated with 1 ng/ml IL-1 evoked a significantly smaller increase in ICa density compared with control cells. This IL-1-mediated decrease in beta-responsiveness was usually observed with pretreatment periods of > 1 h and varied as a function of the L-arginine concentration of the pretreatment medium. In addition, it was prevented by 1) IL-1 receptor antagonist, 2) substituting D-arginine for L-arginine, or 3) incubating cells with the nitric oxide synthase inhibitor NG-monomethyl-L-arginine. Thus the present data illustrate that IL-1 significantly alters the beta-adrenergic control of cardiac Ca2+ channels by cellular mechanisms that involve the activation of nitric oxide synthase. These mechanisms may play a role in altering ventricular function during cytokine-mediated inflammatory processes affecting the heart.

This article has been cited by other articles:

				H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480. [Abstract] [Full Text] [PDF]

				H. Kan, Z. Xie, and M. S. Finkel HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappa B activation Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3138 - H3143. [Abstract] [Full Text] [PDF]

				L. Adam, M. Bouvier, and T. L. Z. Jones Nitric Oxide Modulates beta 2-Adrenergic Receptor Palmitoylation and Signaling J. Biol. Chem., September 10, 1999; 274(37): 26337 - 26343. [Abstract] [Full Text] [PDF]

				A. Kumar, R. Brar, P. Wang, L. Dee, G. Skorupa, F. Khadour, R. Schulz, and J. E. Parrillo Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R265 - R276. [Abstract] [Full Text] [PDF]

				S. J. Liu, W. Zhou, and R. H. Kennedy Suppression of beta -adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H141 - H148. [Abstract] [Full Text] [PDF]

				D. A. De-Souza and L. J. Greene Pharmacological Nutrition After Burn Injury J. Nutr., May 1, 1998; 128(5): 797 - 803. [Abstract] [Full Text]

				G. J. Rozanski, Z. Xu, K. Zhang, and K. P. Patel Altered K+ current of ventricular myocytes in rats with chronic myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H259 - H265. [Abstract] [Full Text] [PDF]

				C. F. McTiernan, B. H. Lemster, C. Frye, S. Brooks, A. Combes, and A. M. Feldman Interleukin-1ß Inhibits Phospholamban Gene Expression in Cultured Cardiomyocytes Circ. Res., October 19, 1997; 81(4): 493 - 503. [Abstract] [Full Text]